vinblastine
Showing 26 - 50 of 69
Hodgkin Lymphoma Trial in Worldwide (brentuximab vedotin, doxorubicin, vinblastine)
Active, not recruiting
- Hodgkin Lymphoma
- brentuximab vedotin
- +5 more
-
Fountain Valley, California
- +75 more
Dec 2, 2022
Hodgkin Lymphoma Trial in Italy (Doxorubicin, Bleomycin, Vinblastine)
Active, not recruiting
- Hodgkin Lymphoma
- Doxorubicin
- +3 more
-
Alessandria, Italy
- +45 more
Dec 22, 2022
Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin
Unknown status
- Adult Lymphocyte Depletion Hodgkin Lymphoma
- +6 more
- brentuximab vedotin
- +11 more
-
Stanford, California
- +6 more
Feb 14, 2020
Hodgkin Disease Trial in Worldwide (Nivolumab, Doxorubicin, Vinblastine)
Active, not recruiting
- Hodgkin Disease
- Nivolumab
- +3 more
-
Los Angeles, California
- +37 more
Oct 25, 2021
Langerhans Cell Histiocytosis Trial in United States (drug, procedure, biological)
Recruiting
- Langerhans Cell Histiocytosis
- Prednisone
- +8 more
-
Birmingham, Alabama
- +35 more
Feb 17, 2022
Ann Arbor Stage I Hodgkin Lymphoma, Ann Arbor Stage I Mixed Cellularity Classic Hodgkin Lymphoma, Ann Arbor Stage I Nodular
Recruiting
- Ann Arbor Stage I Hodgkin Lymphoma
- +13 more
- Bleomycin
- +6 more
-
Birmingham, Alabama
- +16 more
Nov 23, 2021
Metastatic Melanoma Trial in Lebanon (vinblastine, Cyclophosphamide, dacarbazine)
Terminated
- Metastatic Melanoma
- vinblastine
- +2 more
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Dec 26, 2018
Classic Hodgkin Lymphoma, Lugano Classification Stage III Hodgkin Lymphoma AJCC v8, Lugano Classification Stage IV Hodgkin
Hodgkin Lymphoma Trial in Canada, Italy, United Kingdom (biological, drug, radiation)
Completed
- Hodgkin Lymphoma
- bleomycin sulfate
- +4 more
-
Calgary, Alberta, Canada
- +21 more
Apr 13, 2020
Neurofibromatosis Type 1, Precancerous Condition Trial in Philadelphia (Methotrexate, Vinblastine)
Completed
- Neurofibromatosis Type 1
- Precancerous Condition
- Methotrexate
- Vinblastine
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Jul 13, 2018
Hodgkin Disease Trial in Houston (Filgrastim SD/01, Adriamycin, Bleomycin)
Completed
- Hodgkin Disease
- Filgrastim SD/01
- +4 more
-
Houston, TexasUT MD Anderson Cancer Center
Oct 30, 2018
Bladder Cancer Trial in United States (Gemcitabine, Cisplatin, Methotrexate)
Prostate Cancer Trial in Houston (Bicalutamide, Doxorubicin HCl, Estramustine Phosphate Sodium)
Completed
- Prostate Cancer
- Bicalutamide
- +8 more
-
Houston, TexasUniversity of Texas - MD Anderson Cancer Center
Oct 30, 2018
Hodgkin Lymphoma Trial in Cologne (Doxorubicine, DTIC, Lenalidomide)
Completed
- Hodgkin Lymphoma
- Doxorubicine
- +3 more
-
Cologne, NRW, Germany1st Dept. of Medicine, Cologne University Hospital
Mar 21, 2018
Lymphoma Trial in United States (doxorubicin HCl, vinblastine, standard subtotal nodal irradiation)
Completed
- Lymphoma
- doxorubicin hydrochloride
- +2 more
-
La Jolla, California
- +21 more
Feb 16, 2017
Bladder Cancer, Muscle-invasive Bladder Cancer Trial in Boston, Burlington, Pittsburgh (Methotrexate, Doxorubicin, vinblastine)
Completed
- Bladder Cancer
- Muscle-invasive Bladder Cancer
- Methotrexate
- +4 more
-
Boston, Massachusetts
- +3 more
Sep 9, 2016
Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor Trial in Canada, United States (cisplatin, ifosfamide, paclitaxel)
Terminated
- Extragonadal Germ Cell Tumor
- Testicular Germ Cell Tumor
- cisplatin
- +3 more
-
Anniston, Alabama
- +78 more
Jul 1, 2016
Lymphoma Trial in United States (doxorubicin HCl, gemcitabine HCl, vinblastine)
Completed
- Lymphoma
- doxorubicin hydrochloride
- +4 more
-
San Francisco, California
- +46 more
Jun 30, 2016
Hodgkin Lymphoma Trial in Milano (Bleomycin, Etoposide, Doxorubicin)
Completed
- Hodgkin Lymphoma
- Bleomycin
- +8 more
-
Milano, ItalyFondazione IRCCS Istituto Nazionale di Tumori di Milano
Aug 11, 2015